Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Next-generation Sequencing03:00

Next-generation Sequencing

88.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.8K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.0K
Forced Transdifferentiation01:28

Forced Transdifferentiation

1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
1.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Tibiotalocalcaneal arthrodesis using a retrograde intramedullary nail and augmented allograft after failed total ankle replacement: an exploratory retrospective matched cohort study.

Orthopaedics & traumatology, surgery & research : OTSR·2026
Same author

The Significance of Angiopoietin Valency in Vascular Health and Disease.

Cells·2026
Same author

Designed Minibinders Rewire Receptor Signaling to Enable Functional Human Myogenic Reprogramming.

bioRxiv : the preprint server for biology·2026
Same author

Epigenetic control of PDX1 and NGN3 by a computationally designed PRC2 inhibitor enforces pancreatic endocrine differentiation from pluripotent stem cells.

Research square·2026
Same author

Loss of function of the chromatin remodeling gene <i>INO80D</i> leads to neurogenic features of schizophrenia.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Soluble Notch agonist enables human ameloblast maturation and enamel-like tissue formation for tooth regeneration.

International journal of oral science·2026
Same journal

A mechanistic study on the enhanced antihypertensive effects of a <i>Dendrobium officinale</i> compound combined with Western antihypertensive drugs in spontaneously hypertensive rats based on metabolomics and gut microbiota analysis.

Frontiers in cell and developmental biology·2026
Same journal

From pathophysiology to therapy: molecular mechanisms of stem cell and extracellular vesicle-mediated repair in diabetic peripheral neuropathy.

Frontiers in cell and developmental biology·2026
Same journal

The gut-brain axis: mechanisms linking intestinal dysbiosis with stroke.

Frontiers in cell and developmental biology·2026
Same journal

Towards a bioengineered airway: advances in tracheal tissue engineering and biofabrication.

Frontiers in cell and developmental biology·2026
Same journal

Targeting nuclear receptors in muscular dystrophies and regenerative myogenesis.

Frontiers in cell and developmental biology·2026
Same journal

Risk-centered benchmarking of large language models for AI-enabled counseling in chronic autoimmune thyroid eye disease.

Frontiers in cell and developmental biology·2026
查看所有相关文章

相关实验视频

Updated: Jul 2, 2025

Direct Reprogramming of Mouse Fibroblasts into Melanocytes
09:38

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

2.1K

下一代直接重编程是下一代直接重编程.

Riya Keshri1,2, Damien Detraux1,2, Ashish Phal1,2,3

  • 1Department of Biochemistry, School of Medicine, University of Washington, Seattle, WA, United States.

Frontiers in cell and developmental biology
|February 19, 2024
PubMed
概括
此摘要是机器生成的。

衰老会损害组织的修复,导致疾病. 使用人工智能设计的蛋白质工具的新型直接重编程方法显示出增强细胞修复和对抗纤维化和退行性疾病等与年龄有关的疾病的前景.

关键词:
老化的老化 衰老的老化心脏肌肉的心脏肌肉的心脏肌肉直接重新编程是直接的重编程.部分重新编程部分重编程开拓者因素 开拓者因素信号传输 信号传输这是骨肌肉的骨架肌肉.通过转差异化转化.

更多相关视频

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors
11:46

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

6.4K
In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

4.9K

相关实验视频

Last Updated: Jul 2, 2025

Direct Reprogramming of Mouse Fibroblasts into Melanocytes
09:38

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

2.1K
Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors
11:46

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

6.4K
In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

4.9K

科学领域:

  • 生物医学工程 生物医学工程
  • 再生医学是一种再生医学.
  • 分子生物学分子生物学

背景情况:

  • 衰老显著影响组织修复,导致心肌梗塞和阿尔茨海默病等主要疾病.
  • 目前的重编程方法在有效性,细胞成熟度和有针对性的传递方面面临挑战.
  • 细胞外信号通路和表观遗传修饰是细胞命运决定的关键.

研究的目的:

  • 引入新的直接重编程策略,解决当前的局限性.
  • 探索先进的蛋白质设计技术在细胞重编程中的潜力.
  • 为减少衰老,纤维化和退行性疾病提供未来的分子策略.

主要方法:

  • 使用人工智能设计的迷你结合剂来调节受体氨酸激酶 (RTK) 和受体氨酸/氨酸激酶 (RSTK).
  • 采用人工智能设计的表观遗传酶和先驱因素来操纵细胞命运.
  • 研究细胞外信号通路和细胞重编程中的表观遗传标记.

主要成果:

  • 建议人工智能驱动的蛋白质设计作为直接重编程挑战的解决方案.
  • 突出了RTK,RSTK和表观遗传标记在细胞重新连接中的核心作用.
  • 该研究概述了一条通往高效转差和直接重编程的途径.

结论:

  • 新型蛋白质设计技术为克服直接重编程障碍提供了一个有希望的途径.
  • 对信号通路和表观遗传标记的有针对性的调节可以增强细胞修复.
  • 未来的应用可能包括通过重新编程来减少衰老,纤维化和退行性疾病的集体减少.